LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 38 filers reported holding LYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,808 | -25.7% | 18,621 | -4.5% | 0.00% | – |
| Q3 2022 | $98,000 | -43.7% | 19,496 | +29.7% | 0.00% | – |
| Q1 2021 | $174,000 | -21.6% | 15,036 | -22.7% | 0.00% | – |
| Q4 2020 | $222,000 | +26.9% | 19,450 | +24.3% | 0.00% | – |
| Q3 2020 | $175,000 | +15.9% | 15,643 | +18.1% | 0.00% | – |
| Q2 2020 | $151,000 | – | 13,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,780,261 | $11,426,873 | 2.01% |
| Nantahala Capital Management | 3,957,542 | $16,265,497 | 1.57% |
| Perceptive Advisors | 12,757,562 | $52,433,579 | 1.52% |
| PURA VIDA INVESTMENTS, LLC | 1,413,242 | $5,717,732 | 0.76% |
| Ikarian Capital, LLC | 978,626 | $4,022,153 | 0.64% |
| VR Adviser, LLC | 924,170 | $3,798,339 | 0.61% |
| Parkman Healthcare Partners LLC | 600,000 | $2,466,000 | 0.43% |
| DAFNA Capital Management LLC | 361,084 | $1,484,055 | 0.41% |
| Soleus Capital Management, L.P. | 592,417 | $2,434,834 | 0.27% |
| ARMISTICE CAPITAL, LLC | 4,012,036 | $16,489,468 | 0.24% |